Indianapolis, Indiana 46202

  • Alcoholism


The aims of this protocol are to compare 3 and 6 months of naltrexone treatment coupled with two psychotherapies that differ in scope and intensity. The effect of these treatments will be assessed with patients who differ in their psychosocial need and resources at their disposal, and in their level of cravings for alcohol.


Inclusion Criteria: - Meets current diagnosis of alcohol dependence and have been abstinent for a minimum of 3 and maximum of 21 days prior to treatment - Must be able to participate in an 18-month outpatient study, and live within a one hour or less commute to treatment facility. - Must be fluent in English. - Women of childbearing potential must have a negative pregnancy test. Exclusion Criteria: - Severe hepatic disease or a liver function test greater than 4 times normal. - Opiate use in the last 14 days or a history of opioid dependence in the past year. - Pregnant or lactating females who are not using a reliable method of birth control. - Inability to follow medication instructions and safety precautions. - Comorbid substance dependence diagnosis in the past 6-months, excluding nicotine or marijuana dependence. - Use of medications intended to decrease drinking. - Meets criteria for bipolar disorder, schizophrenia, bulimia/anorexia, dementia, major depression.



Primary Contact:


Backup Contact:


Location Contact:

Indianapolis, Indiana 46202
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.